Table 2 Distribution of clinical characteristics, management and concentration of inflammatory biomarkers in children with definite bacterial pneumonia, presumed viral pneumonia and other pneumonia
Parameter | Definite bacterial pneumonia (N = 30), A | Presumed viral pneumonia, (N = 118) B | Other pneumonia, (N = 82) C |
|---|---|---|---|
Clinical features | |||
Fever (body temperature ≥ 38.0 °C) | 27 (90) λ** μ*** | 71 (60) | 41 (50) |
Age-specific Tachypnoea | 9 (30) | 56 (47) δ** | 22 (27) |
SpO2% at presentation, median (IQR) | 96 (94, 98) | 95 (93, 98) | 95 (94, 97) |
Diagnosis of wheeze at presentation | 0 (0) | 18 (15) | 11 (13) |
Diagnosis of crackles/crepitation at presentation | 8 (27) | 58 (49) | 42 (52) |
Cough | 24 (80) | 109 (92) | 75 (91) |
Rhinorrhea | 12 (40) | 93 (79) δ*** λ *** | 41 (50) |
Difficulty in breathing | 25 (83) | 88 (75) | 62 (76) |
Vomiting | 19 (63) | 78 (66) | 39 (48) |
Body rash | 3 (10) | 14 (12) | 12 (15) |
Diarrhea | 8 (27) | 34 (29) | 15 (18) |
Poor oral intake | 22 (73) | 82 (69) | 61 (74) |
Clinical management | |||
Supplemental O2 | 16 (53) | 65 (55) | 35 (43) |
Intravenous fluid | 22 (73) μ*** λ* | 60 (51) δ** | 25 (31) |
Respiratory support | 1 (3) | 2 (2) | 3 (4) |
Supplemental O2 + intravenous fluid | 16 (53) μ** λ* | 38 (32) | 19 (23) |
Hospitalization day, median (IQR) | 8 (4, 11) μ*** λ*** | 2 (1, 3) | 2 (1, 3) |
Blood inflammatory markers | |||
WCC count (×109/L), median (IQR) | 16 (11, 21) λ* | 11 (8, 18) | 12 (8, 18) |
CRP (mg/L), median (IQR) | 174 (64, 246) λ*** μ*** | 24 (13, 56) | 27 (17, 59) |
Absolute neutrophil, (×109/L), median (IQR) | 13 (8, 19) λ** μ** | 7 (4, 13) | 8 (4, 13) |